Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.
Ishikawa T, Kokura S, Enoki T, Sakamoto N, Okayama T, Ideno M, Mineno J, Uno K, Yoshida N, Kamada K, Katada K, Uchiyama K, Handa O, Takagi T, Konishi H, Yagi N, Naito Y, Itoh Y, Yoshikawa T.
Ishikawa T, et al. Among authors: itoh y.
PLoS One. 2014 Jan 31;9(1):e83786. doi: 10.1371/journal.pone.0083786. eCollection 2014.
PLoS One. 2014.
PMID: 24497917
Free PMC article.
Clinical Trial.